[1] Recent biochemical and medical aspects: International Symposium, February 17–18, 1981, Max-Planck-Institute for Biochemistry, Martinsried/Munich, Germany

Book

[1] Recent biochemical and medical aspects

International Symposium, February 17–18, 1981, Max-Planck-Institute for Biochemistry, Martinsried/Munich, Germany

Edited by: A. Henschen , H. Graeff and F. Lottspeich

Part of the multi-volume work

Fibrinogen. Proceedings/ Workshop on Fibrinogen

Language: German

Published/Copyright: 1982

Published by

Become an author with De Gruyter Brill

Explore this Subject How to publish with us

Topics

Frontmatter Publicly Available Download PDF	I
PREFACE Publicly Available Download PDF	V
CONTENTS Publicly Available Download PDF	VII
I. PHYSICOCHEMICAL ASPECTS
PARACRYSTALLINE STRUCTURE OF NATIVE HUMAN FIBRINOGEN Rotraut Gollwitzer, Wolfram Bode, Hans-Josef Schramm, Dieter Typke and Reinhard Guckenberger Requires Authentication Unlicensed Licensed	3
DETERMINATION OF FIBRIN STRUCTURES BY LIGHT SCATTERING Walther Burchard and Michael Müller Requires Authentication Unlicensed Licensed	11
PARTICULARITIES OF FIBRINOGEN, ROD-LIKE AND BRANCHED FIBRINS Michael Müller and Walther Burchard Requires Authentication Unlicensed Licensed	29
TEMPERATURE EFFECTS ON FIBRIN(OGEN)-FIBRIN SOLUTIONS (Preliminary results) Pierre Wiltzius and Werner Känzig Requires Authentication Unlicensed Licensed	43
HYDRODYNAMIC CHARACTERIZATION OF PLASMIN DEGRADATION PRODUCTS PROM HUMAN FIBRINOGEN Alfons C. M. van der Drift and Aldi Poppema Requires Authentication Unlicensed Licensed	47
THE KINETICS OF FIBRIN FORMATION R. Eberhard Zimmermann Requires Authentication Unlicensed Licensed	59
II. BIOCHEMICAL ASPECTS
STRUCTURE - FUNCTION - EVOLUTION RELATIONSHIP IN FIBRINOGEN Agnes Henschen, Friedrich Lottspeich, Maria Kehl, Chris Southan and John Lucas Requires Authentication Unlicensed Licensed	67
ARTIFACTUAL HETEROGENEITY OF HUMAN FIBRINOGEN POLYPEPTIDE CHAINS CAUSED BY CARBOXYMETHYLATION Cemal Kuyas, André Haeberli and P. Werner Straub Requires Authentication Unlicensed Licensed	83
INFLUENCE OF SIALIC ACID ON THE ADULT AND FETAL FIBRINOGEN-FIBRIN TRANSITION Irene Witt, Hans H. Seydewitz and Volker Dahlacker Requires Authentication Unlicensed Licensed	91
FIBRIN FORMATION IN THE PRESENCE OF TRYPSIN Birgit Hessel, Birger Blombäck and Sonja Söderman Requires Authentication Unlicensed Licensed	101
CHARACTERISATION OF RAT FIBRINOGEN Maria Kehl and Agnes Henschen Requires Authentication Unlicensed Licensed	109
CHARACTERISATION OF PIG FIBRINOGEN John Lucas and Agnes Henschen Requires Authentication Unlicensed Licensed	115
III. ABNORMAL FIBRINOGENS
ON DYSFIBRINOGENEMIA Rudolf Marx and Wolfgang Schramm Requires Authentication Unlicensed Licensed	123
DETECTION OF FIBRINOGEN ABNORMALITY IN DYSFIBRINOGENEMIA SPECIAL REPORT ON FIBRINOGEN METZ CHARACTERIZED BY AN AMINO ACID SUBSTITUTION LOCATED AT THE PEPTIDE BOND CLEAVED BY THROMBIN. Jeannette Soria, Claudine Soria, Meyer Samama, Agnes Henschen and Chris Southan Requires Authentication Unlicensed Licensed	129
BINDING OF CITRATE TO NORMAL FIBRINOGEN AND TO METZ FIBRINOGEN P. Ladure, Y. Ricordel, J. Soria, C. Soria and M. Samama Requires Authentication Unlicensed Licensed	145
THE SEARCH FOR MOLECULAR DEFECTS IN ABNORMAL FIBRINOGENS Chris Southan, Agnes Henschen and Friedrich Lottspeich Requires Authentication Unlicensed Licensed	153
FIBRINOGEN BERN I: A HEREDITARY FIBRINOGEN VARIANT WITH DEFECTIVE CONFORMATIONAL STABILIZATION BY CALCIUM IONS Christoph Rupp, Cemal Kuyas, André Haberli, Miha Furlan, Beat A. Perret and Eugene A. Beck Requires Authentication Unlicensed Licensed	167
CARBOHYDRATE IN ABNORMAL FIBRINOGENS David A. Lane, Antony K. Alien, John Markwick, Elisabeth Thompson and Ian Ilackie Requires Authentication Unlicensed Licensed	183
OBSERVATION ON A NEW VARIANT OF HEREDITARY DYSFIBRINOGENEMIA (HDMBURG I) WITH DELAYED FIBRIN POLYMERIZATION AND WITHOUT CLINICAL ABNORMALITY Chieko Miyashita, Karl-Heinz Nienhaus, Ernst Wenzel, Michael Köhler and Peter Hellstern Requires Authentication Unlicensed Licensed	193
IV. FIBRINOPEPTIDE DETERMINATION
FPA-RELEASE IN NORMAL AND ABNORMAL FIBRINOGEN Wolfgang Schramm and Rudolf Marx Requires Authentication Unlicensed Licensed	201
SIMULTANEOUS CLINICAL EVALUATION OF RADIOIMMUNOASSAYS FOR FIBRINOPEPTIDES AND g-THROMBOGLOBULIN David A. Lane, Helen Ireland and Sylvia Wolff Requires Authentication Unlicensed Licensed	207
ANALYSIS OF HUMAN FIBRINOPEPTIDES BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY : QUANTITATIVE DETERMINATION AND KINETICS OF RELEASE Maria Kehl, Friedrich Lottspeich and Agnes Henschen Requires Authentication Unlicensed Licensed	217
V. FIBRINOGEN - FIBRIN COMPLEXES
SOLUBLE FIBRINOGEN-FIBRIN COMPLEXES IN PLASMA AT 37°C Peter Kierulf and Frank Brosstad Requires Authentication Unlicensed Licensed	229
SOLUBLE DES-AA FIBRIN CLEARANCE IN HEALTHY HUMAN SUBJECTS Frank Brosstad, Tor Hamborg, Bjørn Holm, Hans C. Godal and Peter Kierulf Requires Authentication Unlicensed Licensed	231
COMPLEX FORMATION OF SOLUBLE FIBRIN POLYMERS WITH AGAROSECOUPLED FIBRINOGEN AND FIBRIN WITH REGARD TO THEIR MOLECULAR WEIGHT René von Hugo, Reimar Hafter and Herner Graeff Requires Authentication Unlicensed Licensed	233
TEMPERATURE-DEPENDENT REVERSIBLE ASSOCIATION AND DISSOCIATION OF SOLUBLE FIBRIN IN PLASMA Gert Müller-Berghaus, Ingo Mahn, Wolfgang Krell and Johannes-Christoph Bernhard Requires Authentication Unlicensed Licensed	237
NO COMPLEX FORMATION OF DES-AB FIBRIN WITH FIBRINOGEN INVESTIGATED BY THE HUMMEL AND DREYER PROCEDURE Ingo Mahn, Wolfgang Krell and Gert Müller-Berghaus Requires Authentication Unlicensed Licensed	249
VI. FIBRIN(OGEN) DEGRADATION AND CROSSLINKED FIBRIN DERIVATIVES
ON THE STRUCTURE OF D-FRAGMENTS OF HUMAN FIBRINOGEN AND FIBRIN Willem Nieuwenhuizen, Anton Vermond and Frits Haverkate Requires Authentication Unlicensed Licensed	255
ROLE OF THE C-TERMINUS OF THE FIBRINOGEN y-CHAIN IN FIBRINOGEN Ca²⁺ BINDING AND IN FIBRIN POLYMERIZATION Frits Haverkate and Willem Nieuwenhuizen Requires Authentication Unlicensed Licensed	265
FIBRINOGEN DEGRADATION BY GRANULOCYTE ELASTÄSE AND CATHEPSIN G - GENERATION OF FIBRINOGEN DEGRADATION PRODUCTS WITH ANTICOAGULANT PROPERTIES Margarethe Gramse and Christine Bingenheimer Requires Authentication Unlicensed Licensed	271
A SIMPLE METHOD FOR QUANTIFICATION OF FIBRINOGEN-CHAINS AND EARLY SPLIT-PRODUCTS IN SDS-DISC-ELECTROPHORESIS Thomas Wuppermann, Norbert Folke Rath, Hans Jürgen Zielonka and Matti Seppo Kestilä Requires Authentication Unlicensed Licensed	285
HOMOLOGUES OF FIBRIN X OLIGOMERS Reimar Hafter and Henner Graeff Requires Authentication Unlicensed Licensed	291
FIBRIN FRAGMENTATION BY PLASMIN: MOLECULAR CONSIDERATIONS AND THEIR RELEVANCE TO DIC AND THROMBOSIS Patrick J. Gaffney Requires Authentication Unlicensed Licensed	307
FIBRINOGEN IN LIVER CIRRHOSIS. FIBRIN MONOMER COMPLEXES AND DYSFIBRINOGENAEMIA WITH HIGH SIALIC ACID CONTENT Sergio Coccheri, Gualtiero Palareti and Mario Poggi Requires Authentication Unlicensed Licensed	329
INFLUENCE OF VARIOUS THROMBIN FORMATION RATES ON THE FIBRIN STABILIZATION PROCESS Monika Barthels Requires Authentication Unlicensed Licensed	339
SOME OBSERVATION ON CONCENTRATION AND COAGULABILITY OF FIBRINOGEN IN PATIENTS WITH CANCER, WITH AND WITH3UT METASTASIS Chieko Miyashita, Elena Dumitrescu, Ernst Wenzel and Richard Johannes Meiser Requires Authentication Unlicensed Licensed	347
VII. BIOLOGICAL EFFECTS OF LOW MOLECULAR WEIGHT PEPTIDES AND INTERACTION WITH OTHER PROTEINS
EFFECTS OF PEPTIDES DERIVED FROM FIBRINOGEN PROTEOLYSIS ON IMMUNEREACTIONS AND TUMOR GROWTH Maria Kopec, Waldemar Roszkowski, Bengt Gerdin and Tom Saldeen Requires Authentication Unlicensed Licensed	355
PLASMIN AND ELASTASE INDUCED FIBRIN DEGRADATION PRODUCTS AND THEIR ACTION ON VASCULAR PERMEABILITY: AN EXPERIMENTAL STUDY Marie-Luise Schmeller, Reimar Hafter, Axel Stemberger, Henner Graeff and Günther Blümel Requires Authentication Unlicensed Licensed	361
THE EFFECT OF REPEATED INJECTIONS OF FIBRINOPEPTIDES A AND B ON EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN RATS AND GUINEA PIGS Gerhard Ruhenstroth-Bauer, Rainer Scherer, M. Abd-El-Fattah and Jiri Simon Requires Authentication Unlicensed Licensed	365
INTERACTION OF FIBRINOGEN WITH ITS PLATELET RECEPTOR REQUIRES THE NATIVE STRUCTURE OF THE MOLECULE AND DIVALENT IONS Gerard Marguerie and Edward F. Plow Requires Authentication Unlicensed Licensed	369
STUDIES ON THE BINDING OF TISSUE PLASMINOGEN ACTIVATOR TO FIBRINOGEN AND FIBRIN Egbert K.O. Kruithof and Fedor Bachmann Requires Authentication Unlicensed Licensed	377
FIBRIN BINDING AND TRANSAMIDATION REACTIVE DOMAINS OF FIBRONECTIN Helmut Hörmann, Martin Seidl and Hartmut Richter Requires Authentication Unlicensed Licensed	389
AUTHOR INDEX Requires Authentication Unlicensed Licensed	397
SUBJECT INDEX Requires Authentication Unlicensed Licensed	399
Backmatter Requires Authentication Unlicensed Licensed	401

Publishing information

Pages and Images/Illustrations in book

eBook published on:

July 22, 2019

eBook ISBN:

9783110865325

Hardcover published on:

June 1, 1982

Hardcover ISBN:

9783110085433

Edition:

Reprint 2019

Pages and Images/Illustrations in book

Front matter:

10

Main content:

400

Other:

Num. figs.

https://doi.org/10.1515/9783110865325

eBook ISBN: 9783110865325

Hardcover ISBN: 9783110085433

Safety & product resources

Manufacturer information:
Walter de Gruyter GmbH
Genthiner Straße 13
10785 Berlin
productsafety@degruyterbrill.com

[1] Recent biochemical and medical aspects

Overview

Topics

Table of contents

Bibliographic data